WWM
RMD icon

Western Wealth Management’s ResMed RMD Stock Holding History

Western Wealth Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,231
Closed -$236K – 763
2024
Q2 		$236K Buy
+1,231
New +$250K 0.02% 577

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Western Wealth Management's RMD Position: Q3 2024 in Review

Western Wealth Management sold out of ResMed (RMD) in Q3 2024, closing a stake of 1,231 shares — an estimated $236K sold.

Western Wealth Management first reported a position in RMD in Q2 2024 and held it in 1 quarter. The position peaked at $236K in Q2 2024. 801 funds tracked by Wall St. Rank hold RMD as of Q3 2024.

  • Western Wealth Management reported no remaining ResMed position as of Q3 2024 after selling out during the quarter.
  • Western Wealth Management sold 1,231 ResMed shares in Q3 2024, an estimated $236K.
  • Western Wealth Management first reported a position in ResMed in Q2 2024 and held it in 1 quarter.
  • Western Wealth Management's ResMed position peaked at $236K in Q2 2024.
  • 801 funds tracked by Wall St. Rank held ResMed as of Q3 2024.

Based on Western Wealth Management's 13F filing for Q3 2024, filed 12 Nov 2024.